Jade Biosciences, Inc.
JBIO
$13.66
-$0.32-2.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -127.41M | -- | -- | -- | |
| Total Depreciation and Amortization | 26.00K | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 40.89M | -- | -- | -- | |
| Change in Net Operating Assets | -8.20M | -- | -- | -- | |
| Cash from Operations | -94.69M | -- | -- | -- | |
| Capital Expenditure | -196.00K | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -246.81M | -- | -- | -- | |
| Cash from Investing | -247.01M | -- | -- | -- | |
| Total Debt Issued | 0.00 | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 385.38M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -24.62M | -- | -- | -- | |
| Cash from Financing | 360.77M | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -21.00K | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 19.05M | -- | -- | -- | |